Our Business
Supbio focuses on precision diagnostics for major infectious diseases and oncology. Powered by SUPBIO Microscale-Precision Technologies, our ultra-sensitive quantitative detection platform supports innovative products and solutions for public health agencies (CDC), healthcare providers, pharmaceutical companies, research institutions, and individual users worldwide. Our portfolio includes precision molecular diagnostics, drug resistance analysis, co-enrichment of extracellular vesicles (EVs) and viruses, as well as third-party laboratory testing and collaborative research services. Together, these capabilities support early detection, precision treatment, and advances in therapeutic development.
Learn More
Supbio advances precision diagnostics through continuous technological innovation. Built on SUPBIO Microscale-Precision Technologies,our solutions enable ultra-sensitive molecular detection and accurate quantification of low-abundance targets. From research and development to quality management and global regulatory certification, we have established an integrated pathway that supports the translation of scientific discoveries into clinical and industrial applications. Our technologies continue to expand the role of precision diagnostics in addressing major diseases.
We are committed to building an open, collaborative, and sustainable innovation ecosystem
Integrating R&D, manufacturing, clinical practice,and end-user services to create seamless partnership models
Through technology sharing and resource integration, we help partners strengthen their innovation and service capabilities
Working with multinational companies, leading distributors,and regional service providers to support integration into international healthcare systems
Delivering solutions tailored to regional needs to ensure effective local implementation
We believe in long-term partnerships that strengthen the healthcare ecosystem and create sustainable value